These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 39408276)

  • 21. Restoration of Parkinson's Disease-Like Deficits by Activating Autophagy through mTOR-Dependent and mTOR-Independent Mechanisms in Pharmacological and Transgenic Models of Parkinson's Disease in Mice.
    Pupyshev AB; Tenditnik MV; Ovsyukova MV; Akopyan AA; Dubrovina NI; Tikhonova MA
    Bull Exp Biol Med; 2021 Aug; 171(4):425-430. PubMed ID: 34542745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial Effects of Trehalose on Striatal Dopaminergic Deficits in Rodent and Primate Models of Synucleinopathy in Parkinson's Disease.
    Howson PA; Johnston TH; Ravenscroft P; Hill MP; Su J; Brotchie JM; Koprich JB
    J Pharmacol Exp Ther; 2019 Jun; 369(3):364-374. PubMed ID: 30918068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Gut Microbiota Alterations on Motor, Gastrointestinal, and Behavioral Phenotype in a Mouse Model of Parkinson's Disease.
    Radisavljevic N; Cirstea M; Bauer K; Lo C; Metcalfe-Roach A; Bozorgmehr T; Bar-Yoseph H; Brett Finlay B
    J Parkinsons Dis; 2022; 12(5):1479-1495. PubMed ID: 35599496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [
    Wang F; Zhang Z; Sun Y; Yang L; Guo T; Pan Y; Ding S; Jiang L; Liu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):876-884. PubMed ID: 38862445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut brain axis: an insight into microbiota role in Parkinson's disease.
    Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
    Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of α-synuclein aggregates to the intestinal environment recapitulates Parkinsonian symptoms in model systems.
    Yang ZX; Zhang Y; Wang Q; Zhang L; Liu YF; Zhang Y; Ren Y; Zhou C; Gao HW; Zhang NX; Feng LY
    Acta Pharmacol Sin; 2024 Jan; 45(1):36-51. PubMed ID: 37684382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
    Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.
    Sampson TR; Debelius JW; Thron T; Janssen S; Shastri GG; Ilhan ZE; Challis C; Schretter CE; Rocha S; Gradinaru V; Chesselet MF; Keshavarzian A; Shannon KM; Krajmalnik-Brown R; Wittung-Stafshede P; Knight R; Mazmanian SK
    Cell; 2016 Dec; 167(6):1469-1480.e12. PubMed ID: 27912057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal microbiota from patients with Parkinson's disease intensifies inflammation and neurodegeneration in A53T mice.
    Yang H; Shao Y; Hu Y; Qian J; Wang P; Tian L; Ni Y; Li S; Al-Nusaif M; Liu C; Le W
    CNS Neurosci Ther; 2024 Aug; 30(8):e70003. PubMed ID: 39161161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
    Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-
    Zhao Z; Li F; Ning J; Peng R; Shang J; Liu H; Shang M; Bao XQ; Zhang D
    Acta Pharm Sin B; 2021 Sep; 11(9):2859-2879. PubMed ID: 34589401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease.
    Yan Y; Ren S; Duan Y; Lu C; Niu Y; Wang Z; Inglis B; Ji W; Zheng Y; Si W
    NPJ Biofilms Microbiomes; 2021 Sep; 7(1):69. PubMed ID: 34475403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
    Kim DS; Choi HI; Wang Y; Luo Y; Hoffer BJ; Greig NH
    Cell Transplant; 2017 Sep; 26(9):1560-1571. PubMed ID: 29113464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease.
    Bhattarai Y; Si J; Pu M; Ross OA; McLean PJ; Till L; Moor W; Grover M; Kandimalla KK; Margolis KG; Farrugia G; Kashyap PC
    Gut Microbes; 2021 Jan; 13(1):1866974. PubMed ID: 33459114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
    Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
    Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coffee and Parkinson's disease.
    Asuku AO; Ayinla MT; Olajide TS; Oyerinde TO; Yusuf JA; Bayo-Olugbami AA; Fajemidagba GA
    Prog Brain Res; 2024; 289():1-19. PubMed ID: 39168575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Neuroprotective Effect of Gut Microbe in Parkinson's Disease: An In Silico and In Vivo Approach.
    Bhardwaj K; Rajawat NK; Mathur N; Kaushik A
    Neuromolecular Med; 2024 Aug; 26(1):32. PubMed ID: 39090268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
    Nielsen SD; Pearson NM; Seidler K
    Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
    Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
    Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.